Search for: "Human Genome Sciences Inc. v. Genentech Inc."
Results 1 - 11
of 11
Sorted by Relevance
|
Sort by Date
11 Mar 2011, 8:46 am
The complaint in Human Genome Sciences Inc. v. [read post]
30 Jan 2011, 9:53 pm
Human Genome Sciences Inc. v. [read post]
30 Mar 2008, 8:24 pm
Human Genome Sciences Inc. v. [read post]
24 Apr 2011, 8:43 pm
Genentech, Inc. et al. v. [read post]
19 Dec 2008, 8:07 am
" Human Genome Sciences Inc. v. [read post]
15 Dec 2011, 9:00 am
"Human Genome Sciences Inc., et. al. v. [read post]
19 Dec 2008, 1:00 pm
(IP Kenya) UK: Damages for observing patent injunction: Les Laboratoires Servier & Anor v Apotex Inc & Ors (IP finance) US/China: ‘Eli Lilly lobbies on counterfeiting and regulatory issues involving China’ (IP Dragon) US: Federal judge dismisses patent lawsuit filed by Human Genome Sciences against Genentech over patent related to type of protein that can be used to detect tumours (Law360) US: MedImmune seeks… [read post]
1 Mar 2011, 8:38 pm
(Maier & Maier) US: Undermining a preliminary injunction via patent reexamination: Celsis In Vitro v CellzDirect (Patents Post Grant Blog) US: Human Genome Sciences’ lawsuit alleges Genentech, Celltech colluded to fraudulently extend Cabilly patent (GenericsWeb) US: Regeneron files for declaratory judgment of non-infringement and/or invalidity of Genentech patents based on it biological license application for VEGF Trap (Patent Docs) US… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
9 Nov 2015, 7:39 am
Common general knowledge ('CGK')While many CGK propositions were agreed between the parties, there was still much uncertainty surrounding this area of science at the priority date. [read post]
